Hemolytic anemia during 24 weeks of ribavirin and interferon-α2b combination therapy does not influence the cardiac function of patients with viral hepatitis C

被引：0
|
作者：
Sato, S [1 ]
Furuta, K
Miyake, T
Mishiro, T
Kohge, N
Akagi, S
Uchida, Y
Rumi, MAK
Ishihara, S
Adachi, K
Kinoshita, Y
机构：
[1] Shimane Univ, Sch Med, Dept Gastroenterol & Hepatol, Matsue, Shimane, Japan
[2] Shimane Univ Hosp, Div Gastrointestinal Endoscopy, Matsue, Shimane, Japan
来源：
JOURNAL OF CLINICAL GASTROENTEROLOGY | 2006年 / 40卷 / 01期
关键词：
D O I：
10.1097/01.mcg.0000190781.96021.20
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：88 / 89
页数：2
相关论文
共 50 条
  • [31] Risk factors for retinopathy associated with interferonα-2b and ribavirin combination therapy in patients with chronic hepatitis C
    Chiaki Okuse
    Hiroshi Yotsuyanagi
    Yoshihiko Nagase
    Yuhtaro Kobayashi
    Kiyomi Yasuda
    Kazuhiko Koike
    Shiro Iino
    Michihiro Suzuki
    Fumio Itoh
    World Journal of Gastroenterology, 2006, (23) : 3756 - 3759
  • [32] Risk factors for retinopathy associated with interferon α-2b and ribavirin combination therapy in patients with chronic hepatitis C
    Okuse, Chiaki
    Yotsuyanagi, Hiroshi
    Nagase, Yoshihiko
    Kobayashi, Yuhtaro
    Yasuda, Kiyomi
    Koike, Kazuhiko
    Iino, Shiro
    Suzuki, Michihiro
    Itoh, Fumio
    WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (23) : 3756 - 3759
  • [33] IMPACT OF THE VIRAL KINETICS OF CHRONIC HEPATITIS C PATIENTS TREATED WITH TELAPREVIR IN COMBINATION WITH PEGYLATED INTERFERON α2b AND RIBAVIRIN
    Ogawa, E.
    Furusyo, N.
    Nakamuta, M.
    Kajiwara, E.
    Nomura, H.
    Dohmen, K.
    Takahashi, K.
    Satoh, T.
    Azuma, K.
    Kawano, A.
    Tanabe, Y.
    Kotoh, K.
    Shimoda, S.
    Hayashi, J.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S365 - S365
  • [34] Response of hepatitis C genotype-4 naive patients to 24 weeks of peg-interferon-α2b/ribavirin or induction-dose interferon-α2b/ribavirin/amantadine:: A non-randomized controlled study
    El-Zayadi, AR
    Attia, M
    Barakat, EMF
    Badran, HM
    Hamdy, H
    El-Tawil, A
    El-Nakeeb, A
    Selim, O
    Saied, A
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (11): : 2447 - 2452
  • [35] Interleukin-2 plus ribavirin versus interferon-α-2b plus ribavirin in patients with chronic hepatitis C who did not respond to previous interferon-α-2b treatment
    Malaguarnera, M
    Pistone, G
    Neri, S
    Romano, M
    Brogna, A
    Musumeci, S
    BIODRUGS, 2004, 18 (06) : 407 - 413
  • [36] Interleukin-2 Plus Ribavirin Versus Interferon-α-2b Plus Ribavirin in Patients with Chronic Hepatitis C Who Did Not Respond to Previous Interferon-α-2b Treatment
    Mariano Malaguarnera
    Giovanni Pistone
    Sergio Neri
    Marcello Romano
    Alfio Brogna
    Salvatore Musumeci
    BioDrugs, 2004, 18 : 407 - 413
  • [37] Factors associated with hemolytic anemia in patients with chronic hepatitis C treated with combination of interferon and ribavirin
    Hou, C
    Yu, ML
    Dai, CY
    Chuang, WL
    Chen, SC
    Lin, ZY
    Wang, LY
    Chang, WY
    JOURNAL OF HEPATOLOGY, 2002, 36 : 236 - 236
  • [38] Interferon-α and ribavirin combination therapy for hepatitis C in HIV-coinfected patients
    Rockstroh, JK
    Klausen, G
    Gölz, J
    Dupke, S
    Stein, L
    Notheis, G
    Stoehr, A
    Pascucci, GR
    Wasmuth, JC
    Mauss, S
    AIDS, 2000, 14 : S123 - S123
  • [39] Long-term efficacy of combination therapy with interferon-α2b and ribavirin for severe chronic hepatitis C in HIV-infected patients
    Landau, A
    Batisse, D
    Piketty, C
    Van Huyen, LPD
    Bloch, F
    Belec, L
    Bruneval, P
    Weiss, L
    Jian, R
    Kazatchkine, MD
    AIDS, 2001, 15 (16) : 2149 - 2155
  • [40] From trials to a real hospital setting:: Effectiveness of pegylated interferon-α-2b/ribavirin combination therapy for naive chronic hepatitis C patients
    Piai, Guido
    Scalice, Elisa
    Focareta, Rosaria
    Terracciano, Fulvia
    de Filippo, Francesca Romana
    Forte, Giovambattista
    DIGESTIVE DISEASES AND SCIENCES, 2006, 51 (09) : 1619 - 1626
12345